Loading…
Loading…
On 7 October 2025, Stockwik Förvaltning AB (“Stockwik” or the “Company”) announced that the board of directors, based on the authorisation granted by the annual general meeting on 16 May 2025, had resolved on a directed share issue of 900,000 shares (the “Share Issue”) to ENDI Corp. at a subscription price of SEK 23,00 per share, subject to the Swedish Inspectorate for Strategic Products (Sw. Inspektionen för strategiska produkter ) granting clearance of ENDI Corp's investment in Stockwik (the “FDI Clearance”) pursuant to the Swedish Screening of Foreign Direct Investments Act (Sw. lagen (2023:560) om granskning av utländska direktinvesteringar ). On 11 November 2025, the Company announced that ENDI Corp. had obtained the FDI Clearance. ENDI Corp. has now subscribed and paid for the shares and the Share Issue has been registered with the Swedish Companies Registration Office.
On 7 October 2025, Stockwik Förvaltning AB (“Stockwik” or the “Company”) announced that the board of directors, based on the authorisation granted by the annual general meeting on 16 May 2025, had resolved on a directed share issue of 900,000 shares (the “Share Issue”) to ENDI Corp at a subscription price of SEK 23 per share, subject to the Swedish Inspectorate for Strategic Products (Sw. Inspektionen för strategiska produkter ) granting clearance of ENDI Corp's investment in Stockwik (the “FDI Clearance”) pursuant to the Swedish Screening of Foreign Direct Investments Act (Sw. lagen (2023:560) om granskning av utländska direktinvesteringar ). The FDI Clearance has now been obtained and ENDI Corp shall, in accordance with its subscription undertaking, subscribe and pay for the shares in the Share Issue no later than on 17 November 2025.
ENDI Corp's shares rose significantly, driven by a substantial increase in AUM and a value-unlocking transaction, suggesting further upside potential. Finch Therapeutics awaits a post-trial decision that could significantly impact its share value, with a minimum award level already set. Nam Tai Property secured significant financing and sold a non-core property above appraisal value, indicating a potential closing of the gap between market price and fair value.
PLEASANTVILLE, N.Y. , June 28, 2024 /PRNewswire/ -- CrossingBridge Advisors, LLC ("CrossingBridge") is pleased to announce a strategic partnership with NCI Advisory A/S ("NCI Advisory"), a strong performing debt asset management firm based in Denmark.
GLEN ALLEN, Va. , April 1, 2024 /PRNewswire/ -- ENDI Corp. (OTCQB: ENDI) ("ENDI" or the "Company") announced its financial results for the year ending December 31, 2023, in connection with filing its annual report on Form 10-K with the Securities and Exchange Commission.
Glen Allen, VA, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ENDI Corp. (OTCQB: ENDI) (“ENDI” or the “Company”) today announced its intention to deregister its Class A common stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), by filing a Form 15 with the U.S. Securities and Exchange Commission (the “SEC”) on or about January 12, 2024. The filing of the Form 15 will immediately suspend ENDI's obligation to file current and periodic reports pursuant to the Exchange Act, and effective 90-days thereafter, is expected to terminate the registration of the Company's Class A common stock under Section 12(g) of the Exchange Act. The Company still intends to file a Form 10-K annual report for its fiscal year ended December 31, 2023 in accordance with SEC requirements.
No recent filings indexed.